Multiple Myeloma Clinical Trial
PRospective Multiple Myeloma Impact Study
Summary
This will be a prospective, case-only, study to measure the impact of MMprofiler on treatment intention decisions in Multiple Myeloma patients.
Full Description
This will be a prospective, case-only, study to measure the impact of MMprofiler on treatment intention decisions in MM patients.
Eligible patients will have their tumor sample analyzed for the prognostic MMprofiler SKY92, several cytogenetic markers, gene expression markers, and gene expression clusters.
A total of 250 patients will be enrolled from up to 9 US centers. Patients will be followed 5 years after diagnosis.
Eligibility Criteria
Inclusion Criteria:
Potentially multiple myeloma according to IMWG criteria
Candidates for systemic treatment
Exclusion Criteria:
ECOG Performance Status > 3
Tumor sample that fails QA or QC criteria for MMprofiler
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There are 9 Locations for this study
Washington District of Columbia, 20007, United States
Atlanta Georgia, 30322, United States
Hackensack New Jersey, 07601, United States
Brooklyn New York, 11215, United States
New York New York, 10032, United States
New York New York, 10065, United States
Charlotte North Carolina, 28204, United States
Winston-Salem North Carolina, 27157, United States
Milwaukee Wisconsin, 53226, United States
How clear is this clinincal trial information?